RxDoctor Payments Data

Padmajarani Gottipolu

Family Medicine · Plano, TXNPI 1295792299

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2019 at $637 and has fallen 79.3% since, to $132 in 2022.

$1,132in general payments, 2019–2025

Across 73 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$306
  • AstraZeneca$223
  • GSK$214
  • Merck$79
  • Lilly USA, LLC$41
  • Genentech USA, Inc.$30
  • plus $238 from 13 others

What the payments were for

  • Food & beverage$1,132100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,132 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Other family medicine in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →